News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,127 Results
Type
Article (87443)
Company Profile (760)
Press Release (772901)
Multimedia
Podcasts (174)
Webinars (28)
Section
Business (233060)
Career Advice (4140)
Deals (39795)
Drug Delivery (137)
Drug Development (91252)
Employer Resources (203)
FDA (18285)
Job Trends (17399)
News (397402)
Policy (39926)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (125)
Alliances (56979)
ALS (146)
Alzheimer's disease (1681)
Antibody-drug conjugate (ADC) (245)
Approvals (18311)
Artificial intelligence (496)
Autoimmune disease (77)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (161)
Biotechnology (484)
Bladder cancer (133)
Brain cancer (53)
Breast cancer (510)
Cancer (3984)
Cardiovascular disease (339)
Career advice (3559)
Career pathing (38)
CAR-T (247)
CDC (57)
Cell therapy (687)
Cervical cancer (33)
Clinical research (75560)
Collaboration (1396)
Company closure (4)
Compensation (940)
Complete response letters (59)
COVID-19 (2959)
CRISPR (81)
C-suite (597)
Cystic fibrosis (136)
Data (4532)
Decentralized trials (2)
Denatured (62)
Depression (112)
Diabetes (455)
Diagnostics (7093)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (236)
Drug pricing (190)
Drug shortages (36)
Duchenne muscular dystrophy (204)
Earnings (98828)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (133043)
Executive appointments (992)
FDA (20769)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1258)
Gene editing (173)
Generative AI (50)
Gene therapy (548)
GLP-1 (1022)
Government (5385)
Grass and pollen (7)
Guidances (343)
Healthcare (20937)
HIV (48)
Huntington's disease (38)
IgA nephropathy (63)
Immunology and inflammation (242)
Immuno-oncology (21)
Indications (53)
Infectious disease (3205)
Inflammatory bowel disease (188)
Inflation Reduction Act (15)
Influenza (101)
Intellectual property (192)
Interviews (815)
IPO (17927)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (16)
Labor market (77)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (12)
Lung cancer (575)
Lymphoma (266)
Machine learning (31)
Management (66)
Manufacturing (643)
MASH (140)
Medical device (14872)
Medtech (14897)
Mergers & acquisitions (22749)
Metabolic disorders (1160)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (230)
Neuropsychiatric disorders (61)
Neuroscience (2721)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (559)
Opinion (314)
Ovarian cancer (135)
Pain (166)
Pancreatic cancer (172)
Parkinson's disease (242)
Partnered (30)
Patents (423)
Patient recruitment (315)
Peanut (57)
People (66272)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23309)
Phase II (32796)
Phase III (24712)
Pipeline (2737)
Policy (295)
Postmarket research (3554)
Preclinical (10503)
Press Release (72)
Prostate cancer (201)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (679)
Real estate (7421)
Recruiting (78)
Regulatory (28034)
Reports (65)
Research institute (2690)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (73)
Schizophrenia (136)
Series A (208)
Series B (156)
Service/supplier (30)
Sickle cell disease (81)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (95)
The Weekly (110)
Vaccines (1052)
Venture capital (67)
Weight loss (396)
Women's health (59)
Worklife (21)
Date
Today (156)
Last 7 days (738)
Last 30 days (2646)
Last 365 days (33619)
2025 (26663)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (303)
Arkansas (14)
Asia (50987)
Australia (8960)
California (9492)
Canada (2874)
China (906)
Colorado (403)
Connecticut (425)
Delaware (271)
Europe (117137)
Florida (1398)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (813)
India (51)
Indiana (463)
Iowa (20)
Japan (327)
Kansas (124)
Kentucky (38)
Louisiana (21)
Maine (78)
Maryland (1280)
Massachusetts (7139)
Michigan (315)
Minnesota (564)
Mississippi (4)
Missouri (121)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2641)
New Mexico (32)
New York (2586)
North Carolina (1416)
North Dakota (10)
Northern California (4301)
Ohio (299)
Oklahoma (22)
Oregon (50)
Pennsylvania (1977)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (49)
South Dakota (1)
Southern California (3625)
Tennessee (150)
Texas (1491)
United States (35108)
Utah (283)
Virginia (250)
Washington D.C. (83)
Washington State (822)
West Virginia (4)
Wisconsin (97)
Wyoming (1)
There are 861,127 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capital
Biotech Markets Turn Positive but Experts Say Don’t Call It a Comeback—Yet
M&A is back, the S&P XBI is rising again, a biotech pulled off an IPO and positive data is pulling in investors again. This may just be the industry’s new normal.
October 22, 2025
·
7 min read
·
Annalee Armstrong
Podcast
Novo Board Upended, ESMO Excitement, FDA Awards, Replimune’s U-Turn
Novo Nordisk’s leadership gets another shake-up as President Trump promises to significantly slash prices for its GLP-1 drugs; Summit/Akeso, Exelixis and more present new data at ESMO 2025; Replimune pops as FDA accepts resubmitted BLA; FDA names first winners of Commissioner’s National Priority Voucher program; and more.
October 22, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Genmab Commences Tender Offer for All Issued and Outstanding Common Shares of Merus N.V.
October 22, 2025
·
4 min read
Press Releases
Notice convening an Extraordinary General Meeting of Novo Nordisk A/S
October 22, 2025
·
1 min read
Press Releases
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering
October 22, 2025
·
4 min read
Press Releases
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
October 22, 2025
·
3 min read
Press Releases
Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025
October 22, 2025
·
1 min read
Press Releases
Avalyn Announces Multiple Presentations at the Pulmonary Fibrosis Foundation (PFF) Summit 2025
October 22, 2025
·
4 min read
Press Releases
Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET
October 22, 2025
·
2 min read
Press Releases
Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week
October 22, 2025
·
5 min read
1 of 86,113
Next
